Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Am. J. Epidemiol.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schwarcz, S.
Right arrow Articles by Weinstock, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarcz, S.
Right arrow Articles by Weinstock, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 153, No. 10 : 925-934
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


ORIGINAL CONTRIBUTIONS

Differences in the Temporal Trends of HIV Seroincidence and Seroprevalence among Sexually Transmitted Disease Clinic Patients, 1989–1998: Application of the Serologic Testing Algorithm for Recent HIV Seroconversion

Sandra Schwarcz1, Timothy Kellogg1, William McFarland1, Brian Louie1, Robert Kohn1, Michael Busch2, Mitchell Katz1, Gail Bolan3, Jeff Klausner1 and Hillard Weinstock4

1 San Francisco Department of Public Health, San Francisco, CA.
2 Blood Centers of the Pacific, San Francisco, CA.
3 California Department of Health Services, Berkeley, CA.
4 Centers for Disease Control and Prevention, Atlanta, GA.

The authors compared temporal trends in the prevalence and incidence of human immunodeficiency virus (HIV) infection based upon 34,866 specimens from patients who attended the San Francisco, California, municipal sexually transmitted disease clinic between 1989 and 1998. HIV infection data were collected during annual blinded HIV serologic surveys. Incidence was determined by applying a serologic testing algorithm for recent HIV seroconversion that uses both a sensitive and a less sensitive enzyme immunoassay to stored HIV positive sera. The HIV seroprevalence declined from 15.2% in 1989 to 7.2% in 1998 (odds ratio per year = 0.92, 95% confidence interval (CI): 0.91, 0.94). Among homosexual men, the HIV prevalence declined from 50.9% in 1989 to 19.9% in 1998 (odds ratio per year = 0.86, 95% CI: 0.85, 0.88). The pooled seroincidence was 1.6% and did not change significantly over time (odds ratio per year = 1.0, 95% CI: 0.98, 1.1). The pooled seroincidence among homosexual men was 6.6% per year and remained steady between 1989 and 1998 (odds ratio per year = 0.99, 95% CI: 0.92, 1.1). During a dramatic, 10-year decline in seroprevalence of HIV infection, the incidence of HIV infection remained remarkably stable.

acquired immunodeficiency syndrome; HIV; incidence; prevalence; sexually transmitted diseases

Abbreviations: CI, confidence interval; EIA, enzyme-linked immunosorbent assay; HIV, human immunodeficiency virus; HIV-1, human immunodeficiency virus type 1; IDU, injection drug user; LS, less sensitive; MSM, men who have sex with men; OR, odds ratio; STARHS, Serologic Testing Algorithm for Recent HIV Serocon-version; STD, sexually transmitted disease


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Am. J. Epidemiol.:

Invited Commentary: Should We Estimate Incidence for Undefined Populations?
Victor J. Schoenbach, Charles Poole, and William C. Miller
Am. J. Epidemiol. 2001 153: 935-937. [Extract] [FREE Full Text]  

Schwarcz et al. Respond to "Should We Estimate Incidence for Undefined Populations?"
Sandra Schwarcz, William McFarland, Mitchell Katz, and Hillard Weinstock
Am. J. Epidemiol. 2001 153: 938. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
AJPHHome page
H. Thiede, R. A. Jenkins, J. W. Carey, R. Hutcheson, K. K. Thomas, R. D. Stall, E. White, I. Allen, R. Mejia, and M. R. Golden
Determinants of Recent HIV Infection Among Seattle-Area Men Who Have Sex with Men
Am J Public Health, April 1, 2009; 99(S1): S157 - S164.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
V. Lakshmi, T. Sudha, R. Dandona, V. D. Teja, G. A. Kumar, and L. Dandona
Application of human immunodeficiency virus type 1 BED enzyme immunoassay on dried blood spots in India
J. Med. Microbiol., March 1, 2009; 58(3): 312 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Loschen, J. Batzing-Feigenbaum, G. Poggensee, C. Cordes, B. Hintsche, M. Rausch, S. Dupke, S. Gohlke-Micknis, J. Rodig, O. Hamouda, et al.
Comparison of the Human Immunodeficiency Virus (HIV) Type 1-Specific Immunoglobulin G Capture Enzyme-Linked Immunosorbent Assay and the Avidity Index Method for Identification of Recent HIV Infections
J. Clin. Microbiol., January 1, 2008; 46(1): 341 - 345.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Chawla, G. Murphy, C. Donnelly, C. L. Booth, M. Johnson, J. V. Parry, A. Phillips, and A. M. Geretti
Human Immunodeficiency Virus (HIV) Antibody Avidity Testing To Identify Recent Infection in Newly Diagnosed HIV Type 1 (HIV-1)-Seropositive Persons Infected with Diverse HIV-1 Subtypes
J. Clin. Microbiol., February 1, 2007; 45(2): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. R. Cole, H. Chu, and R. Brookmeyer
Confidence Intervals for Biomarker-based Human Immunodeficiency Virus Incidence Estimates and Differences using Prevalent Data
Am. J. Epidemiol., January 1, 2007; 165(1): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
E. Martro, B. Suligoi, V. Gonzalez, V. Bossi, A. Esteve, J. Mei, V. Ausina, and and the Recent HIV Infections Study Group
Comparison of the Avidity Index Method and the Serologic Testing Algorithm for Recent Human Immunodeficiency Virus (HIV) Seroconversion, Two Methods Using a Single Serum Sample for Identification of Recent HIV Infections
J. Clin. Microbiol., December 1, 2005; 43(12): 6197 - 6199.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
F. Barin, L. Meyer, R. Lancar, C. Deveau, M. Gharib, A. Laporte, J.-C. Desenclos, and D. Costagliola
Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum Spots
J. Clin. Microbiol., September 1, 2005; 43(9): 4441 - 4447.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. A. de Freitas Oliveira, M. Ueda, R. Yamashiro, R. Rodrigues, H. W. Sheppard, and L. F. de Macedo Brigido
Rate and Incidence Estimates of Recent Human Immunodeficiency Virus Type 1 Infections among Pregnant Women in Sao Paulo, Brazil, from 1991 to 2002
J. Clin. Microbiol., March 1, 2005; 43(3): 1439 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
T R Chadborn, C A McGarrigle, P A Waight, and K A Fenton
Trends in, and determinants of, HIV testing at genitourinary medicine clinics and general practice in England, 1990-2000
Sex Transm Inf, April 1, 2004; 80(2): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
B. Suligoi, C. Galli, M. Massi, F. Di Sora, M. Sciandra, P. Pezzotti, O. Recchia, F. Montella, A. Sinicco, and G. Rezza
Precision and Accuracy of a Procedure for Detecting Recent Human Immunodeficiency Virus Infections by Calculating the Antibody Avidity Index by an Automated Immunoassay-Based Method
J. Clin. Microbiol., November 1, 2002; 40(11): 4015 - 4020.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
M. H. Katz, S. K. Schwarcz, T. A. Kellogg, J. D. Klausner, J. W. Dilley, S. Gibson, and W. McFarland
Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco
Am J Public Health, March 1, 2002; 92(3): 388 - 394.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
V. J. Schoenbach, C. Poole, and W. C. Miller
Invited Commentary: Should We Estimate Incidence for Undefined Populations?
Am. J. Epidemiol., May 15, 2001; 153(10): 935 - 937.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Schwarcz, W. McFarland, M. Katz, and H. Weinstock
Schwarcz et al. Respond to "Should We Estimate Incidence for Undefined Populations?"
Am. J. Epidemiol., May 15, 2001; 153(10): 938 - 938.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.